Popular Trials
CAR T-cell Therapy
Kappa CD28 T Cells for Leukemia
Recruiting1 awardPhase 1
Houston, Texas
This trial is testing a new treatment for patients with a type of cancer called NHL, Multiple Myeloma (MM) or CLL that has come back or has not gone away after treatment. The treatment is a gene transfer research study using special immune cells. The study is testing whether combining two different ways of fighting disease, antibodies and T cells, will be more effective than using either method alone.
Popular Filters
Trials for Burkitt Lymphoma Patients
F-Glutamine PET Imaging for Cancer
Recruiting1 awardPhase 1
New York, New York
This trial is testing a new drug called F-Glutamine that helps find tumors using special scanners. It is aimed at patients who might have tumors. The drug is injected and tracked by the scanner to show where tumors might be. F-Glutamine has been evaluated for its safety in patients with metastatic colorectal cancer.
CAR T-cell Therapy
EBV-Specific Cytotoxic T-Lymphocytes for Lymphoma
Recruiting1 awardPhase 1
Houston, Texas
This trial is for people with Hodgkin or non-Hodgkin lymphoma, T/NK-lymphoproliferative disease, or severe chronic active Epstein Barr Virus (CAEBV) that has come back or is at risk of coming back.
CAR T-cell Therapy
Genetically Modified T cells for Leukemia and Lymphoma
Recruiting1 awardPhase 1
New York, New York
This trial is testing the safety of giving patients modified T-cells from a donor. The goal is to see if these cells cause any toxicities in patients with relapsed B cell leukemia or lymphoma.
Monoclonal Antibodies
Combination Therapy for Mantle Cell Lymphoma
Recruiting1 awardPhase 2
Anchorage, Alaska
This trial is studying a combination of rituximab, bortezomib, bendamustine, and lenalidomide to see how well it works compared with rituximab and bendamustine, followed by rituximab alone or with lenalidomide, in treating mantle cell lymphoma.
Trials for Follicular Lymphoma Patients
F-Glutamine PET Imaging for Cancer
Recruiting1 awardPhase 1
New York, New York
This trial is testing a new drug called F-Glutamine that helps find tumors using special scanners. It is aimed at patients who might have tumors. The drug is injected and tracked by the scanner to show where tumors might be. F-Glutamine has been evaluated for its safety in patients with metastatic colorectal cancer.
CAR T-cell Therapy
EBV-Specific Cytotoxic T-Lymphocytes for Lymphoma
Recruiting1 awardPhase 1
Houston, Texas
This trial is for people with Hodgkin or non-Hodgkin lymphoma, T/NK-lymphoproliferative disease, or severe chronic active Epstein Barr Virus (CAEBV) that has come back or is at risk of coming back.
CAR T-cell Therapy
Genetically Modified T cells for Leukemia and Lymphoma
Recruiting1 awardPhase 1
New York, New York
This trial is testing the safety of giving patients modified T-cells from a donor. The goal is to see if these cells cause any toxicities in patients with relapsed B cell leukemia or lymphoma.
Monoclonal Antibodies
Combination Therapy for Mantle Cell Lymphoma
Recruiting1 awardPhase 2
Anchorage, Alaska
This trial is studying a combination of rituximab, bortezomib, bendamustine, and lenalidomide to see how well it works compared with rituximab and bendamustine, followed by rituximab alone or with lenalidomide, in treating mantle cell lymphoma.
Trials for CD30 Positive Patients
CAR T-cell Therapy
CAR-T Cell Therapy for Lymphoma
Recruiting1 awardPhase 1
Chapel Hill, North Carolina
This trial tests a new treatment using lab-modified immune cells to target and kill cancer cells in patients with certain types of lymphoma that haven't responded to other treatments. The modified cells are designed to better locate and destroy cancer cells. This new approach extends the capacity of the patient's own immune cells to detect and eliminate cancer cells.
CAR T-cell Therapy
Immunotherapy for Lymphoma
Recruiting1 awardPhase 1 & 2
Milwaukee, Wisconsin
This trial tests a new treatment where a patient's immune cells are enhanced to better fight cancer. It targets adults whose CD30+ cancer has come back or resisted other treatments. The enhanced cells are designed to specifically attack cancer cells, making the immune system more effective against the disease.
Trials With No Placebo
F-Glutamine PET Imaging for Cancer
Recruiting1 awardPhase 1
New York, New York
This trial is testing a new drug called F-Glutamine that helps find tumors using special scanners. It is aimed at patients who might have tumors. The drug is injected and tracked by the scanner to show where tumors might be. F-Glutamine has been evaluated for its safety in patients with metastatic colorectal cancer.
CAR T-cell Therapy
EBV-Specific Cytotoxic T-Lymphocytes for Lymphoma
Recruiting1 awardPhase 1
Houston, Texas
This trial is for people with Hodgkin or non-Hodgkin lymphoma, T/NK-lymphoproliferative disease, or severe chronic active Epstein Barr Virus (CAEBV) that has come back or is at risk of coming back.
CAR T-cell Therapy
Genetically Modified T cells for Leukemia and Lymphoma
Recruiting1 awardPhase 1
New York, New York
This trial is testing the safety of giving patients modified T-cells from a donor. The goal is to see if these cells cause any toxicities in patients with relapsed B cell leukemia or lymphoma.
Monoclonal Antibodies
Combination Therapy for Mantle Cell Lymphoma
Recruiting1 awardPhase 2
Anchorage, Alaska
This trial is studying a combination of rituximab, bortezomib, bendamustine, and lenalidomide to see how well it works compared with rituximab and bendamustine, followed by rituximab alone or with lenalidomide, in treating mantle cell lymphoma.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.